The Potential Neuroprotective Effect of Thymoquinone on Scopolamine-Induced In Vivo Alzheimer’s Disease-like Condition: Mechanistic Insights
Background: Alzheimer’s disease (AD) is a common neurodegenerative disorder without effective treatment. Thymoquinone (TQ) has demonstrated potential in exhibiting anti-inflammatory, anti-cancer, and antioxidant characteristics. Despite TQ’s neuroprotection effect, there is a scarcity of information...
Main Authors: | Hend E. Abo Mansour, Aya Ibrahim Elberri, Mai El-Sayed Ghoneim, Waad A. Samman, Aisha A. Alhaddad, Mahmoud S. Abdallah, Eman I. El-Berri, Mohamed A. Salem, Esraa M. Mosalam |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-09-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/28/18/6566 |
Similar Items
-
Neuroprotective effect of ranolazine improves behavioral discrepancies in a rat model of scopolamine-induced dementia
by: Shereen M. Samir, et al.
Published: (2024-01-01) -
Thymoquinone, a Dietary Bioactive Compound, Exerts Anti-Inflammatory Effects in Colitis by Stimulating Expression of the Colonic Epithelial PPAR-γ Transcription Factor
by: Balaji Venkataraman, et al.
Published: (2021-04-01) -
Ameliorative Effect of Thymoquinone and Thymoquinone Nanoparticles against Diazinon-Induced Hepatic Injury in Rats: A Possible Protection Mechanism
by: Walaa M. Nassar, et al.
Published: (2023-09-01) -
Naringenin protects against scopolamine-induced dementia in rats
by: Hala F. Zaki, et al.
Published: (2014-06-01) -
COVID-19 and Thymoquinone: Clinical Benefits, Cure, and Challenges
by: Shimaa Abd El-Salam El-Sayed, et al.
Published: (2023-01-01)